{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:53:46Z","timestamp":1784613226343,"version":"3.55.0"},"reference-count":23,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/mmr.2015.3361","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T08:31:20Z","timestamp":1424161880000},"page":"323-330","source":"Crossref","is-referenced-by-count":20,"title":["Plasma sphingolipids: Potential biomarkers for severe hepatic fibrosis in chronic hepatitis C"],"prefix":"10.3892","volume":"12","author":[{"given":"JUN-FENG","family":"LI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FENG","family":"QU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SU-JUN","family":"ZHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FENG","family":"REN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUI-LI","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MEI","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN-YU","family":"REN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YU","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHONG-PING","family":"DUAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN-LAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,2,17]]},"reference":[{"key":"key20180108022758_b1-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"key20180108022758_b2-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"key20180108022758_b3-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jhep.2007.02.010","article-title":"The natural history of hepatitis C with severe hepatic fibrosis","volume":"47","author":"Lawson","year":"2007","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"key20180108022758_b4-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2893.2011.01518.x","article-title":"How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?","volume":"19","author":"Sebastiani","year":"2012","journal-title":"J Viral Hepat"},{"key":"key20180108022758_b5-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intrao-bserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key20180108022758_b6-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"key20180108022758_b7-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.febslet.2009.10.058","article-title":"Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids","volume":"584","author":"Milhas","year":"2010","journal-title":"FEBS Lett"},{"issue":"Suppl","key":"key20180108022758_b8-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Bioactive sphingolipids: metabolism and function","volume":"50","author":"Bartke","year":"2009","journal-title":"J Lipid Res"},{"key":"key20180108022758_b9-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nchembio742","article-title":"Host sphingolipid biosynthesis as a target for hepatitis C virus therapy","volume":"1","author":"Sakamoto","year":"2005","journal-title":"Nat Chem Biol"},{"key":"key20180108022758_b10-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2006.05.085","article-title":"Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model","volume":"346","author":"Umehara","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108022758_b11-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1874312901206010123","article-title":"Sphingolipid regulation of tissue fibrosis","volume":"6","author":"Shea","year":"2012","journal-title":"Open Rheumatol J"},{"key":"key20180108022758_b12-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6741-1_10","article-title":"Extracellular and intracellular actions of sphingosine-1-phosphate","volume":"688","author":"Strub","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"key20180108022758_b13-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility","volume":"54","author":"Li","year":"2011","journal-title":"J Hepatol"},{"key":"key20180108022758_b14-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cca.2010.02.063","article-title":"Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C","volume":"411","author":"Ikeda","year":"2010","journal-title":"Clin Chim Acta"},{"key":"key20180108022758_b15-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"e52454","DOI":"10.1371\/journal.pone.0052454","article-title":"Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide","volume":"7","author":"Qu","year":"2012","journal-title":"PLoS One"},{"key":"key20180108022758_b16-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00216-013-7479-8","article-title":"Lipidomic profiling of plasma in patients with chronic hepatitis C infection","volume":"406","author":"Qu","year":"2014","journal-title":"Anal Bioanal Chem"},{"key":"key20180108022758_b17-mmr-12-01-0323","first-page":"210","article-title":"Guideline of prevention and treatment of hepatitis C","volume":"38","author":"Hepatotogy Branch, Infectious and Parasitology branch, Chinese Medical Association","year":"2004","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"key20180108022758_b18-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Group TFMCS Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"key20180108022758_b19-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"key20180108022758_b20-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.22813","article-title":"Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride","volume":"49","author":"Park","year":"2009","journal-title":"Hepatology"},{"key":"key20180108022758_b21-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/he.2000.5762","article-title":"Natural history of hepatitis C: its impact on clinical management","volume":"31","author":"Di Bisceglie","year":"2000","journal-title":"Hepatology"},{"key":"key20180108022758_b22-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.510230607","article-title":"The long-term pathological evolution of chronic hepatitis C","volume":"23","author":"Yano","year":"1996","journal-title":"Hepatology"},{"key":"key20180108022758_b23-mmr-12-01-0323","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/hep.1840360707","article-title":"Fibrosis and disease progression in hepatitis C","volume":"36","author":"Marcellin","year":"2002","journal-title":"Hepatology"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3361\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:10:29Z","timestamp":1747645829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,17]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2,17]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/mmr.2015.3361"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3361","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,17]]}}}